SHILPAMED.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 13:00):

Stats
Šios dienos apimtis	372 554
Vidutinė apimtis	933 801
Rinkos kapitalizacija	53.20B
EPS	INR0 ( 2024-02-12 )
Kita pelno data	( INR0 ) 2024-05-23
Last Dividend	INR1.100 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	-10 881
ATR14	INR1.233 (0.23%)

Tūris Koreliacija

Ilgas: 0.25 (neutral)

Trumpas: -0.62 (weak negative)

Signal:(49.06) Neutral

Shilpa Medicare Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Shilpa Medicare Limited Koreliacija - Valiuta/Žaliavos

0.65
( weak )

0.55
( weak )

-0.64
( weak negative )

0.69
( moderate )

0.08
( neutral )

-0.43
( neutral )

Shilpa Medicare Limited Finansinės ataskaitos

Annual	2022
Pajamos:	INR10.50B
Bruto pelnas:	INR6.34B (60.39 %)
EPS:	INR-3.74

FY	2022
Pajamos:	INR10.50B
Bruto pelnas:	INR6.34B (60.39 %)
EPS:	INR-3.74

FY	2022
Pajamos:	INR11.40B
Bruto pelnas:	INR7.56B (66.31 %)
EPS:	INR7.26

FY	2021
Pajamos:	INR9.00B
Bruto pelnas:	INR6.29B (69.92 %)
EPS:	INR18.13

Financial Reports:

No articles found.

Shilpa Medicare Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.100 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Shilpa Medicare Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.233	2010-09-16
Last Dividend	INR1.100	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	INR8.48	--
Avg. Dividend % Per Year	0.10%	--
Score	0.67	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-14)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.67

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.700	0.15%
2019	INR1.000	0.26%
2020	INR1.100	0.39%
2021	INR1.100	0.25%
2022	INR1.100	0.19%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TIPSINDLTD.NS	Dividend Junior	2023-08-03	Annually	17	0.03%
PEL.NS	Dividend Junior	2023-06-16	Annually	29	1.59%
JAICORPLTD.NS	Dividend Junior	2023-09-04	Annually	17	0.27%
DBCORP.NS	Dividend Knight	2023-08-01	Semi-Annually	15	3.47%
SIGIND.NS	Ex Dividend Junior	2023-09-22	Annually	11	0.62%
MAZDA.NS	Dividend Junior	2023-09-07	Annually	8	1.43%
GUFICBIO.NS	Dividend Junior	2023-09-21	Annually	20	0.04%
BASF.NS	Dividend Junior	2023-07-20	Annually	23	0.18%
PRECWIRE.NS	Dividend Junior	2023-08-28	Semi-Annually	23	1.28%
KALYANIFRG.NS	Dividend Junior	2023-09-13	Annually	17	0.81%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.000597	1.500	-0.0119	-0.0179	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.000377	1.500	-1.115	-1.673	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1.259	1.000	-0.645	-0.645	[3 - 30]
operatingCashFlowPerShareTTM	24.64	2.00	1.787	3.57	[0 - 30]
freeCashFlowPerShareTTM	24.64	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.644	1.000	2.60	2.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.0957	1.000	-0.0864	-0.0864	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.346

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7 041.09	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.000377	2.50	-0.717	-1.673	[0.1 - 1.5]
freeCashFlowPerShareTTM	24.64	2.00	1.787	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	24.64	2.00	1.787	3.57	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-639.65	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.190	1.000	7.74	0	[0.1 - 0.5]
Total Score				-0.690

Shilpa Medicare Limited

Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.